Shareholders voted down Gentiva's Executive Pay via the annual proxy for the second year in a row! Despite leadership's shareholder outreach, the percentage voting against executive pay increased.
We believe that our executive compensation program has been effective in aligning the interests of shareholders and executives, incentivizing the accomplishment of corporate goals, and attracting and retaining talented executives. In deciding how to vote on this Say-on-Pay proposal, please consider that we take into account the following factors regarding developing and overseeing our compensation program, which are described in detail in this proxy statement under the heading “Executive Compensation—Compensation Discussion and Analysis”:
- Enhancing shareholder value by focusing our executives’ efforts on the specific performance metrics that help drive shareholder value;
- Attracting, motivating and retaining executive talent willing to commit to long-term shareholder value creation;
- Incorporating meaningful input from our shareholders based on our shareholder outreach efforts;
- Aligning executive decision making with our business strategy and goal setting;
- Reflecting industry standards, offering competitive total compensation opportunities and balancing the need for talent with reasonable compensation expense; and
- Providing executives with information so that they understand their total compensation and how rewards are generally a function of both organizational and individual performance.
Our Board of Directors, therefore, urges you to approve the compensation of our named executive officers by voting in favor.
Nearly three out of five voting Gentiva shareholders said no, that they opposed the Board's recommendation. I wonder how the employee shareholder vote went.
How are things at Generic Hospice? Any sign of raises? Let me know,